This paper is in the following e-collection/theme issue:

Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1482) JMIR Theme Issue: COVID-19 Special Issue (2388)

Published on in Vol 6, No 2 (2020): Apr-Jun

Preprints (earlier versions) of this paper are available at https://www.medrxiv.org/content/10.1101/2020.04.02.20050930v1, first published .
Estimation of the Probability of Reinfection With COVID-19 by the Susceptible-Exposed-Infectious-Removed-Undetectable-Susceptible Model

Estimation of the Probability of Reinfection With COVID-19 by the Susceptible-Exposed-Infectious-Removed-Undetectable-Susceptible Model

Estimation of the Probability of Reinfection With COVID-19 by the Susceptible-Exposed-Infectious-Removed-Undetectable-Susceptible Model

Authors of this article:

Alexander Victor Okhuese1 Author Orcid Image
Article Authors Cited by (26) Tweetations (15) Metrics

Journals

  1. Chaudhary R, Bakhshi P, Gupta H. Volatility in International Stock Markets: An Empirical Study during COVID-19. Journal of Risk and Financial Management 2020;13(9):208 View
  2. Chaudhary R, Bakhshi P, Gupta H. The performance of the Indian stock market during COVID-19. Investment Management and Financial Innovations 2020;17(3):133 View
  3. Hooten M, Wikle C, Schwob M. Statistical Implementations of Agent‐Based Demographic Models. International Statistical Review 2020;88(2):441 View
  4. Elrashdy F, Aljaddawi A, Redwan E, Uversky V. On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity. Journal of Biomolecular Structure and Dynamics 2021;39(15):5831 View
  5. Arafkas M, Khosrawipour T, Kocbach P, Zielinski K, Schubert J, Mikolajczyk A, Celinska M, Khosrawipour V. Current meta‐analysis does not support the possibility of COVID‐19 reinfections. Journal of Medical Virology 2021;93(3):1599 View
  6. McMahon A, Robb N. Reinfection with SARS-CoV-2: Discrete SIR (Susceptible, Infected, Recovered) Modeling Using Empirical Infection Data. JMIR Public Health and Surveillance 2020;6(4):e21168 View
  7. Vargas-Lara A, Schreiber-Vellnagel V, Ochoa-Hein E, López-Ávila A. SARS-CoV-2: una revisión bibliográfica de los temas más relevantes y evolución del conocimiento médico sobre la enfermedad. NCT Neumología y Cirugía de Tórax 2020;79(3):185 View
  8. SeyedAlinaghi S, Oliaei S, Kianzad S, Afsahi A, MohsseniPour M, Barzegary A, Mirzapour P, Behnezhad F, Noori T, Mehraeen E, Dadras O, Voltarelli F, Sabatier J. Reinfection risk of novel coronavirus (CoVID-19): A systematic ‎review of current evidence. World Journal of Virology 2020;9(5):79 View
  9. Zheng Y, Zhang Q, Ali A, Li K, Shao N, Zhou X, Ye Z, Chen X, Cao S, Cui J, Zhou J, Wang D, Hou B, Li M, Cui M, Deng L, Sun X, Zhang Q, Yang Q, li Y, Wang H, Lei Y, Yu B, Cheng Y, Tong X, Men D, Zhang X. Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months. Virologica Sinica 2021;36(5):869 View
  10. Maheshwari A, Varshney M, Gupta K, Bajpai M. Psychological assessment and lived experiences of recovered COVID-19 patients who presented for convalescent plasma donation. Transfusion Clinique et Biologique 2021;28(3):254 View
  11. Ringlander J, Olausson J, Nyström K, Härnqvist T, Jakobsson H, Lindh M. Recurrent and persistent infection with SARS-CoV-2 – epidemiological data and case reports from Western Sweden, 2020. Infectious Diseases 2021;53(12):900 View
  12. Shankar S, Mohakuda S, Kumar A, Nazneen P, Yadav A, Chatterjee K, Chatterjee K. Systematic review of predictive mathematical models of COVID-19 epidemic. Medical Journal Armed Forces India 2021;77:S385 View
  13. Nawaz Y, Arif M, Shatanawi W. A New Numerical Scheme for Time Fractional Diffusive SEAIR Model with Non-Linear Incidence Rate: An Application to Computational Biology. Fractal and Fractional 2022;6(2):78 View
  14. Koupaei M, Mohamadi M, Yashmi I, Shahabi A, Shabani A, Heidary M, Khoshnood S. Clinical manifestations, treatment options, and comorbidities in COVID‐19 relapse patients: A systematic review. Journal of Clinical Laboratory Analysis 2022;36(5) View
  15. Rezania A, Ghorbani E, Hassanian-Moghaddam D, Faeghi F, Hassanian-Moghaddam H. Novel model prediction time-to-event analysis: data validation and estimation of 200 million cases in the global COVID-19 epidemic. BMJ Open 2023;13(1):e065487 View
  16. Gallichotte E, Quicke K, Sexton N, Fitzmeyer E, Young M, Janich A, Dobos K, Pabilonia K, Gahm G, Carlton E, Ebel G, Ehrhart N, Long S. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis. Microbiology Spectrum 2021;9(3) View
  17. Chadi M, Mousannif H. A Reinforcement Learning Based Decision Support Tool for Epidemic Control: Validation Study for COVID-19. Applied Artificial Intelligence 2022;36(1) View
  18. Euser S, Weenink T, Prins J, Haverkort M, Manders I, van Lelyveld S, Herpers B, Sinnige J, Kalpoe J, Snijders D, Cohen Stuart J, Slijkerman Megelink F, Kapteijns E, den Boer J, Wagemakers A, Souverein D. The Effect of Varying Interval Definitions on the Prevalence of SARS-CoV-2 Reinfections: A Retrospective Cross-Sectional Cohort Study. Diagnostics 2022;12(3):719 View
  19. Kumar A, Shiwalkar N, Shaikh J, Kaur R, Vommaro A, Persaud P, Kichloo A, Rodríguez-Morales A, Sah R. REINFECTION AFTER SARS-COV2 INFECTION: A LOOMING CONCERN. Journal of Experimental Biology and Agricultural Sciences 2020;8(Spl-1-SARS-CoV-2):S114 View
  20. Page A, Diallo S, Wildman W, Hodulik G, Weisel E, Gondal N, Voas D. Computational Simulation Is a Vital Resource for Navigating the COVID-19 Pandemic. Simulation in Healthcare: The Journal of the Society for Simulation in Healthcare 2022;17(1):e141 View
  21. Sciscent B, Eisele C, Ho L, King S, Jain R, Golamari R. COVID-19 reinfection: the role of natural immunity, vaccines, and variants. Journal of Community Hospital Internal Medicine Perspectives 2021;11(6):733 View
  22. Faruk O, Kar S. A Data Driven Analysis and Forecast of COVID-19 Dynamics during the Third Wave Using SIRD Model in Bangladesh. COVID 2021;1(2):503 View
  23. Yortsos Y, Chang J. A Model for Reinfections and the Transition of Epidemics. Viruses 2023;15(6):1340 View
  24. Chisale M, Sinyiza F, Kaseka P, Chimbatata C, Mbakaya B, Wu T, Nyambalo B, Chauma-Mwale A, Chilima B, Yu K, Kayira A. Coronavirus Disease 2019 (COVID-19) Reinfection Rates in Malawi: A Possible Tool to Guide Vaccine Prioritisation and Immunisation Policies. Vaccines 2023;11(7):1185 View
  25. Li C, Zhou T, Zhang P, He J, Liu Y. Investigation of epidemiological and clinical characteristics of people infected with SARS-CoV-2 during the second pandemic of COVID-19 in Chengdu, China. Frontiers in Public Health 2024;12 View
  26. Ebrahimi A, Alesheikh A, Hooshangi N, Sharif M, Mollalo A. Modeling COVID-19 Transmission in Closed Indoor Settings: An Agent-Based Approach with Comprehensive Sensitivity Analysis. Information 2024;15(6):362 View